Loring Wolcott & Coolidge Fiduciary Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-83
Closed -$6K 484
2020
Q4
$6K Buy
+83
New +$5.16K ﹤0.01% 669

Other funds holding HQY

Loring Wolcott & Coolidge Fiduciary Advisors's HQY Position: Q1 2021 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of HealthEquity (HQY) in Q1 2021, closing a stake of 83 shares — an estimated $6K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in HQY in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 285 funds tracked by Wall St. Rank hold HQY as of Q1 2021.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining HealthEquity position as of Q1 2021 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 83 HealthEquity shares in Q1 2021, an estimated $6K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in HealthEquity in Q4 2020 and held it in 1 quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors's HealthEquity position peaked at $6K in Q4 2020.
  • 285 funds tracked by Wall St. Rank held HealthEquity as of Q1 2021.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2021, filed 14 Apr 2021.